This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmaceuticaldistribution today is anything but monolithic. While companies in this space are grappling with issues ranging from inflation and supply chain disruption to workforce scarcity and DSCSA implementation, there’s still plenty of room for smaller players to stake out part of the terrain to call their own.
Stakeholder Mapping involves identifying professionals in the target therapeutic field who would utilize or influence the utilization of the pharmaceutical product. Contacting stakeholders can be key to knowing where they stand upon the release of the pharmaceutical product. What is a Stakeholder Map? Step 1: Identify Key Stakeholders.
The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals on May 29. Altamedics specialises in pharmaceuticaldistribution in hospital settings.
Arthrex distributes its products to 90+ countries across continents and has subsidiaries all over Europe, including in Germany, Austria, Belgium, England and France. billion Source of Income : Pharmaceuticals Robert W. Leonard Steven Schleifer, MD, PhD Company Name : Regeneron Pharmaceuticals DOB : July 7, 1952 Net Worth : $3.5
Natalie Bedford, senior vice president, US PharmaceuticalDistribution Services at McKesson, discusses the unique challenges of distributing specialty drugs.
Pharmaceutical Technology has listed the leading API biologics (protein and peptide) companies in contract marketing based on its intel, insights, and decades-long experience in the sector. The post Leading API biologics (protein and peptide) companies in contract marketing appeared first on Pharmaceutical Technology.
An MSL is a medically specialized representative for pharmaceutical companies. Furthering the pharmaceutical company’s interests is not their primary responsibility; rather it is to promote their concepts and developments. It’s important to first identify all actors who will play a part in the pharmaceuticaldistribution process.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content